(Reuters) – Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the next three months. FILE PHOTO: Gilead Sciences …
See Original Article

The Phase I and Phase II clinical trials of the vaccine for SARS-CoV-2, approved after pre-clinical studies demonstrated safety and immune response, would start across the country next month. Press Trust of India June 30, 2020 00:31:47 IST. India’s first …
See Original Article

Outdoor Voices founder Tyler Haney is taking an active role in her company again after resigning as CEO earlier this year — leaving the company to be run by a male CEO and a mostly male board — the activewear company announced Sunday.
See Original Article

Cloud Accounting Software Market to witness astonishing growth with Key Players | Intuit, Sage, SAP, Oracle(NetSuite), Microsoft, Infor, Epicor, Workday,
See Original Article

MG Hector Plus will be launched in India in July 2020. As of now, MG (Morris Garages) Motor India has listed the new Hector Plus on its official website. Showcased at the Auto Expo 2020, MG Hector Plus will be the automaker’s third product in the country …
See Original Article